newsfilter
← Latest News
ACCESS Newswire·

Pieris Pharmaceuticals Provides Strategic Update and Announces Restructuring

BOSTON, MA / ACCESSWIRE / July 18, 2023 / Pieris Pharmaceuticals, Inc. , a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology platform for